MarketInOut Stock Screener Log In | Sign Up

Lyka Labs Ltd

Healthcare • Biotechnology • Quote as of 10/28/2026 15:14
Lyka Labs Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
Market Capitalization2,928.01 mln
Float30.29 mln
Earnings Date10/30/2026

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-3.24
Reliable

Relative Strength

87 / 100
Strongly outperforming

Debt / Equity

0.53
Moderate leverage

Pre-Tax Margin

-8%
Marginally loss-making

ROE

-8.95
Negative

Business Description

Founded in 1976 and headquartered in Mumbai, Lyka Labs Limited is an Indian pharmaceutical company that produces and sells a broad range of medicines and health products, covering areas such as skin care, pain relief, infection treatment, hormonal therapies, and nutritional supplements. Its products come in many forms, including injections, creams, gels, and lotions, and are sold both within India and in international markets. The company also provides scientific data services, including stability testing and clinical study data, to support product development.

Key Fundamentals

EPS-2.50
ROE-8.95
RPS37.85
ROIC-6.03
ROA-5.15
Interest Cover-3.36
EBITDA, mln4.89
EV / EBITDA704
EV / EBIT-43.75
Revenue, mln1,377
EV / Revenue2.50

Quote Details

Last 77.42
Change -1.58 (-2%)
Open 79.00
Volume 18,892
Turnover 1,462,619
Average Volume 24,090

Financial Ratios

Pre-Tax Profit Margin-8
Current Ratio1.17
Price / Book3.27
Price / Tangible Book3.53
Price / Cash Flow21.40
Price / Free Cash Flow56.90
Debt / Equity0.53
Price / Sales2.17

Financial Strength

Altman Z-Score1.73
Piotroski F-Score 2 / 9
Beneish M-Score-3.24
Price to Intrinsic Value4.80

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -8.18% 9 / 100   
1 Month -9.82% 38 / 100   
2 Months 17.43% 89 / 100   
6 Months 32.46% 87 / 100   
1 Year -17.88% 46 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog